Epidemiology, Prevention, and Treatment of Chemotherapy-Induced Myelosuppression in China: A National Cross-Sectional Study

Bo Shen(Jiangsu Cancer Hospital), Ji‐Feng Feng(Jiangsu Cancer Hospital), Zhigang Peng(Guangxi Medical University), Banzhou Pan(Nanjing General Hospital of Nanjing Military Command), Wangjun Liao(Sun Yat-sen University), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhengxiang Han(Xuzhou Medical College), Huijuan Wang(Beijing Chao-Yang Hospital, Capital Medical University), Yuan Yuan(Tsinghua–Berkeley Shenzhen Institute), Jingjing Liu(Jilin Province Tumor Hospital), Zhuang Yu(Shanghai East Hospital), Hui Guo(Second Affiliated Hospital of Xi'an Jiaotong University), Ting Deng(Tianjin Medical University Cancer Institute and Hospital), Jun Zhang(Sir Run Run Shaw Hospital), Jian Shi(China Design Group (China)), Kangsheng Gu(Anhui Medical University), Jun Liang(Peking University), Shujuan Wen(Xinjiang Medical University), Xiaorong Dong(Huazhong University of Science and Technology), Haifeng Lin(Hainan General Hospital), Yan Qin(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenqi Jiang(Shandong Tumor Hospital), Rui‐Hua Xu(Sun Yat-sen University), Runxiang Yang(Kunming Medical University), Yue Shi(Tsinghua University), Yinglan Chen(Jiangxi Provincial Cancer Hospital), Yan Yu(Binzhou Medical University), Haitao Lan(University of Electronic Science and Technology of China), Bo Jin(Harbin Medical University), Lin Wu(Central South University), Junping Zhang(Indiana University School of Medicine), Rong Ma(Peking University), Gen Lin(Fujian Medical University)
SSRN Electronic Journal
January 1, 2024
Cited by 0


Related Papers